Smith & Nephew (NYSE:SNN) announced on Friday that it is not weighing its options and is not exploring a takeover or a merger. The company made the statement after speculation it could be in talks with Biomet, a U.S.-based competitor.
Smith & Nephew, which is based in England, makes knee replacements and endoscopy technology. Biomet is owned largely by the Blackstone Group (NYSE:BX) and Goldman Sachs (NYSE:GS). The deal is thought to be a good move for Biomet if the company looks to broaden its offerings in the orthopedics market.
Continue Reading Below
Any deal between the two companies could face antitrust hurdles in both countries.